Delivery Order SPE2DB22D2007-SPE2DB24FJ0KB
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $12,287.90 firm-fixed-price delivery order is for the supply of POMALYST 2 MG CAPSULE 21S, a prescription medication. The contract has an ultimate completion date of May 13, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
- This federal contract award, valued at $36,698.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of POMALYST 3 MG CAPSULE 21S, a pharmaceutical product, with a completion date of May 14, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,971.00 Firm Fixed Price Delivery Order contract is for the supply of POMALYST 3 MG CAPSULE 21S, a medical product. The contract has an ultimate completion date of April 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award, valued at $228,295.22, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pomalyst 1 mg capsules, a specialty medication, to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Pomalyst 2 mg capsules. The $22,938.76 firm-fixed-price contract has an ultimate completion date of November 22, 2024. AmerisourceBergen is a for-profit organization registered in the System for Award Management (SAM.gov) and has an extensive history of federal contract awards supporting military and veterans' healthcare programs. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Pomalyst 4 mg capsules (21-count units) with a ceiling value of $41,555.25. This firm fixed price delivery order, with an ultimate completion date of September 10, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and fulfills this order...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,556,781,412 units of the pharmaceutical product POMALYST 3 MG CAPSULE 100S. The $162,093.60 contract was awarded on April 4, 2022 with a completion date of April 25, 2022. Amerisourcebergen Drug Corp, which has an existing indefinite delivery contract with the Department of Justice Federal...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $3,182.23 firm fixed-price delivery order is for the supply of CAPLYTA 21 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of June 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $12,207.62, is a delivery order for pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. The contract has a firm fixed price pricing type and an ultimate completion date of...
- This is a $16,589.43 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of April 14, 2025 and was not set aside for any specific business category. The award is a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FJ0KBDelivery Order
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,287.90, is for the delivery of POMALYST 2 MG CAPSULE 21S, a specialty pharmaceutical product. The contract has an ultimate completion date of April 1, 2024 and is a firm fixed-price arrangement. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp is the prime contractor, and the contract is part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.3k | 3/11/24 |